These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1787967)

  • 1. Monoclonal antibody-porphyrin conjugate for head and neck cancer: the possible magic bullet.
    Donald PJ; Cardiff RD; He DE; Kendall K
    Otolaryngol Head Neck Surg; 1991 Dec; 105(6):781-7. PubMed ID: 1787967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The specific photodynamic effect of monoclonal antibodies conjugated with hematoporphyrin derivative on gastric cancer in vitro and in vivo].
    Lin K
    Zhonghua Yi Xue Za Zhi; 1989 Jan; 69(1):24-7, 4. PubMed ID: 2527079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antitumor activity of bovine serum albumin-mediated conjugate of hematoporphyrin derivative with antigastric cancer monoclonal antibody].
    Zhang YJ; Wang NQ; Liu T; Dong ZW
    Yao Xue Xue Bao; 1990; 25(12):886-90. PubMed ID: 2151781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study of anti-tumor effect with conjugates of monoclonal antibodies and hematoporphyrin derivative].
    Xu SX; Wang NQ; Dong ZW
    Yao Xue Xue Bao; 1989; 24(6):401-6. PubMed ID: 2532854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser photoradiation therapy of cancer following hematoporphyrin sensitization.
    Wile AG; Dahlman A; Burns RG; Berns MW
    Lasers Surg Med; 1982; 2(2):163-8. PubMed ID: 6217388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
    El-Far M; Pimstone N
    Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possible applications for monoclonal antibodies in diagnosis and therapy of head and neck cancers. II. Future role].
    Wustrow TP
    HNO; 1991 Apr; 39(4):121-8. PubMed ID: 2066263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nude mouse xenograft system: a model for photodetection and photodynamic therapy in head and neck squamous cell carcinoma.
    Hill JH; Plant RL; Harris DM; Grossweiner LI; Rok B; Seter AJ
    Am J Otolaryngol; 1986; 7(1):17-27. PubMed ID: 3953966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor xenograft activity with a conjugate of a Vinca derivative and the squamous carcinoma-reactive monoclonal antibody PF1/D.
    Johnson DA; Laguzza BC
    Cancer Res; 1987 Jun; 47(12):3118-22. PubMed ID: 3495327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck.
    Wenig BL; Kurtzman DM; Grossweiner LI; Mafee MF; Harris DM; Lobraico RV; Prycz RA; Appelbaum EL
    Arch Otolaryngol Head Neck Surg; 1990 Nov; 116(11):1267-70. PubMed ID: 2146969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo.
    Bellnier DA; Prout GR; Lin CW
    J Natl Cancer Inst; 1985 Mar; 74(3):617-25. PubMed ID: 3856065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Photodynamic destruction of in vitro cultivated squamous cell carcinoma cells of the head and neck area].
    Wustrow TP; Jocham D; Schramm A; Unsöld E
    Laryngol Rhinol Otol (Stuttg); 1988 Oct; 67(10):532-8. PubMed ID: 2976868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
    Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
    Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light.
    Tochner Z; Mitchell JB; Harrington FS; Smith P; Russo DT; Russo A
    Cancer Res; 1985 Jul; 45(7):2983-7. PubMed ID: 4005837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma.
    Cheng J; Ekberg T; Engström M; Nestor M; Jensen HJ; Tolmachev V; Anniko M
    Laryngoscope; 2007 Jun; 117(6):1013-8. PubMed ID: 17440426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoradiation therapy of head and neck cancer.
    Wile AG; Novotny J; Mason GR; Passy V; Berns MW
    Am J Clin Oncol; 1984 Feb; 7(1):39-43. PubMed ID: 6695852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased effect of neocarzinostatin bound to chimeric Fab fragments of monoclonal antibody A7 on the proliferation of human pancreatic carcinoma].
    Otsuji E; Kobayashi S; Nishida T; Yamamoto K; Matsumura H; Ichikawa D; Okamoto K; Shirasu M; Sakakura C; Kitamura K; Yamaguchi T
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1775-7. PubMed ID: 9757206
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
    Fantozzi RD
    Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the effectiveness of drug-based cancer therapy by electroporation (electropermeabilization).
    Rabussay DP; Nanda GS; Goldfarb PM
    Technol Cancer Res Treat; 2002 Feb; 1(1):71-82. PubMed ID: 12614180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells.
    Steele JK; Liu D; Stammers AT; Whitney S; Levy JG
    Cancer Immunol Immunother; 1988; 26(2):125-31. PubMed ID: 2965972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.